Drugs / TNX-102-B
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01889173 | Jun → Dec 2013 | — | Tonix Pharmaceuticals, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TNX-102-B | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01889173 ↗ |
| Route | Other | “held under the tongue until dissolution” NCT01889173 ↗ |